The Innate Killer Europe Summit is the only dedicated European meeting bringing together leading biopharma who are looking to advance the development of safe, scalable and efficacious innate immunotherapies to market. As the innate immune field explodes onto a global commercial stage, European pioneers are seeking innovative solutions to advance their commercial growth by overcoming key challenges such as: 

• Building high resolution characterisation methods to identify favourable responder innate cell phenotypes 
• Overcoming pre-clinical modelling pitfalls to generate robust and clinically predictive data 
• Achieving scalable engineering strategies for a commercially viable innate cell therapy

This focused and intimate event is the only dedicated forum to helping to foster community and collaboration and leverage some of the hottest European R&D in innate immune therapy development. This is your opportunity engage with thought leaders in immune-oncology and take the spotlight to become this vibrant community’s solution provider of choice.